These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

748 related articles for article (PubMed ID: 28810236)

  • 1. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
    Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
    Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells.
    Weng JH; Yu CC; Lee YC; Lin CW; Chang WW; Kuo YL
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reciprocal regulation of microRNA-99a and insulin-like growth factor I receptor signaling in oral squamous cell carcinoma cells.
    Yen YC; Shiah SG; Chu HC; Hsu YM; Hsiao JR; Chang JY; Hung WC; Liao CT; Cheng AJ; Lu YC; Chen YW
    Mol Cancer; 2014 Jan; 13():6. PubMed ID: 24410957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
    Guo J; Wen N; Yang S; Guan X; Cang S
    Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of miR-16 contributes to tumor progression by activation of tousled-like kinase 1 in oral squamous cell carcinoma.
    Hu S; Wang H; Yan D; Lu W; Gao P; Lou W; Kong X
    Cell Cycle; 2018; 17(18):2284-2295. PubMed ID: 30252587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MiR-126 inhibits the proliferation and invasion of gastric cancer by downregulation of IGF-1R].
    Wang H; Wang G; Tian WL
    Zhonghua Zhong Liu Za Zhi; 2019 Jul; 41(7):508-515. PubMed ID: 31357837
    [No Abstract]   [Full Text] [Related]  

  • 8. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of microRNA-503 by high glucose reduces the migration and proliferation but promotes the apoptosis of human umbilical vein endothelial cells by inhibiting the expression of insulin-like growth factor-1 receptor.
    Hou LJ; Han JJ; Liu Y
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3515-3523. PubMed ID: 29917206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
    Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
    Wang L; Liu H
    Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-4513 mediates the proliferation and apoptosis of oral squamous cell carcinoma cells via targeting CXCL17.
    Xu YX; Sun J; Xiao WL; Liu YS; Yue J; Xue LF; Deng J; Zhi KQ; Wang YL
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3821-3828. PubMed ID: 31115009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor.
    Lin SC; Kao SY; Chang JC; Liu YC; Yu EH; Tseng SH; Liu CJ; Chang KW
    Oncotarget; 2016 Sep; 7(38):61355-61365. PubMed ID: 27542258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7.
    Wang K; Jin J; Ma T; Zhai H
    Biomed Pharmacother; 2017 Jul; 91():517-525. PubMed ID: 28482289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling.
    Ma J; Na S; Wang P; Li J; He S; Liu F
    Cancer Biother Radiopharm; 2024 Mar; 39(2):144-152. PubMed ID: 35549438
    [No Abstract]   [Full Text] [Related]  

  • 19. miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.
    Du Y; Li Y; Lv H; Zhou S; Sun Z; Wang M
    Int J Clin Exp Pathol; 2015; 8(10):12252-9. PubMed ID: 26722410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis.
    Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H
    J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.